Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis
about
Describing the relationship between cat bites and human depression using data from an electronic health recordAntidepressant treatment for postnatal depressionMirtazapine versus other antidepressive agents for depressionAntidepressants versus placebo for depression in primary careMilnacipran versus other antidepressive agents for depressionReboxetine versus other antidepressive agents for depressionMirtazapine versus other anti-depressive agents for depressionFluvoxamine versus other anti-depressive agents for depressionMilnacipran versus other anti-depressive agents for depressionMilnacipran: a unique antidepressant?The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?Emotion-based dispositions to rash action: positive and negative urgencyTreatment of depressive disorders in primary care--protocol of a multiple treatment systematic review of randomized controlled trialsEfficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysisTransglutaminase 2-mediated serotonylation in pulmonary hypertensionThe depression treatment cascade in primary care: a public health perspective.Emerging targets for antidepressant therapiesPsychotropic Drug Use in São Paulo, Brazil--An Epidemiological SurveyA dimensional approach to modeling symptoms of neuropsychiatric disorders in the marmoset monkey.Psychiatric services in primary care settings: a survey of general practitioners in Thailand.Cost-effectiveness of collaborative care including PST and an antidepressant treatment algorithm for the treatment of major depressive disorder in primary care; a randomised clinical trialMetareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.Depression in adults: drug and physical treatments.The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5).Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels.Improving the cost-effectiveness of a healthcare system for depressive disorders by implementing telemedicine: a health economic modeling study.Uptake of depression treatment recommendations among Latino primary care patients.Update in serotonin and bone.Tricyclic antidepressants exhibit variable pharmacological profiles at the α(2A) adrenergic receptor.Dense cranial electroacupuncture stimulation for major depressive disorder--a single-blind, randomized, controlled studySkeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studiesAcupuncture combined with an antidepressant for patients with depression in hospital: a pragmatic randomised controlled trial.Advances in the treatment of depressionEvidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.Pharmacokinetic interaction between nevirapine and nortriptyline in rats: inhibition of nevirapine metabolism by nortriptylineDiagnosis and treatment of major depression 2007.Explaining the variation between practices in the duration of new antidepressant treatment: a database cohort study in primary care.Sociodemographic and clinical factors associated with antidepressant type in a national sample of the home health care elderly.A randomized trial to reduce the prevalence of depression and self-harm behavior in older primary care patients.Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease.
P2860
Q21559577-454C0040-5F2E-499E-8533-13231DB62291Q24193660-BD99D6CD-8155-4CDD-A91D-9F505141049EQ24234046-1FE48474-33ED-4591-9AEB-65241F8AA0BEQ24239979-F95B8789-769A-46B4-8308-3AA0652F78BBQ24240125-A83ECF8F-2494-4710-9B27-55664263DD5BQ24240504-D2AC968B-AEE2-4AA8-AD59-4575D11E58C4Q24245696-617BF45A-3D40-443F-A370-EB6977483B5FQ24245886-D85A11B2-5C0E-4DC8-B813-C808E80647A5Q24246033-A1FB7B07-5198-4F38-A8BE-78D65029FA4DQ24610271-E0C2BE21-B30A-447D-B13E-59FBE982CC8EQ24650519-9D2EDC4A-1A9F-4811-A2B1-4C626E27807BQ24652826-3F757A08-6E09-4B35-8375-E1EC1C1FFBACQ26996682-567E3B03-F80D-4B27-ABB9-583FF7A88C8DQ27022217-FF78004D-20F4-48CE-BDF7-3F768A231ACFQ27027862-08476E06-1CCB-41F6-A7A6-A6030C2B42B7Q27692061-E4878B83-651E-47C2-9506-85A9754FE6D7Q28247614-C3C66220-3E1C-4156-B449-7A7A0BC71A6EQ28547129-F27A0A5D-E934-4508-87FD-7EFA8DA536B6Q30356275-D3B0554D-F9AA-42FC-872D-58AA46A1048EQ33251728-17549433-BA65-47A9-A207-37C0F9F7EB36Q33276241-D9BB0BD9-208E-4016-9B8F-5D3BA141D862Q33303429-762E4120-176D-4034-9CAF-DB0FDA7F9CD4Q33448181-E4C0132A-028E-4360-81D6-2F0EE72BFFA8Q33635906-6975EE90-D5C7-4B59-9A38-80D547F1252BQ33742105-CB0A81EE-A253-47FB-9BE3-ED96BBF9829BQ33897376-DE453FB3-7C26-4FD8-B578-AB3505710CF6Q34022857-0F4EA93E-A313-493D-A97D-A739A4C7209BQ34113148-7806F8FC-FF4D-4490-81B3-C735F030F4DDQ34115836-B2E37BEE-14DB-4E17-B54A-1822D4B052DEQ34125168-CFF7450B-EB9F-4C01-8C21-C059E6656615Q34140313-39267FC8-8A44-4DF1-B65B-5D0192FC61FBQ34417927-882A357C-1F9F-4D09-B866-B1213AF22032Q34496251-9E67912F-DD39-46D0-A5C2-9F4078FF7703Q34590507-0C606751-79A0-44C6-905A-FFF525F8A279Q34597852-B174122D-4CA2-4601-BFC2-BA68F4AC3510Q34675310-FA469BD1-2768-448B-90D6-F78DF3DFE9FCQ35076004-88AB5407-E318-4714-8251-B6F63E6FFAC5Q35528934-F3A85EDB-70E4-43AC-9474-8A01E92CD76EQ36083523-F674BAEF-65F2-4A16-BDDA-7DAA427B0AEEQ36101681-1E8C81EA-9B7F-471D-A40B-774A08ADD410
P2860
Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Efficacy and tolerability of t ...... primary care: a meta-analysis
@ast
Efficacy and tolerability of t ...... primary care: a meta-analysis
@en
Efficacy and tolerability of t ...... primary care: a meta-analysis
@nl
type
label
Efficacy and tolerability of t ...... primary care: a meta-analysis
@ast
Efficacy and tolerability of t ...... primary care: a meta-analysis
@en
Efficacy and tolerability of t ...... primary care: a meta-analysis
@nl
prefLabel
Efficacy and tolerability of t ...... primary care: a meta-analysis
@ast
Efficacy and tolerability of t ...... primary care: a meta-analysis
@en
Efficacy and tolerability of t ...... primary care: a meta-analysis
@nl
P2093
P2860
P356
P1476
Efficacy and tolerability of t ...... primary care: a meta-analysis
@en
P2093
Bruce Arroll
Iain Crombie
Simon Ogston
Steve Macgillivray
P2860
P304
P356
10.1370/AFM.349
P407
P577
2005-09-01T00:00:00Z